Phase 1 Safety and Tolerability Study of ALN-F1202 in Healthy Adults
NCT06669234
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
56
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteer
Interventions
DRUG:
ALN-F1202
DRUG:
Matching Placebo
Sponsor
Regeneron Pharmaceuticals